Surgical Complexity and Outcome During the Implementation Phase of a Robotic Colorectal Surgery Program—A Retrospective Cohort Study

by Catharina Müller, Johannes Laengle, Stefan Riss, Michael Bergmann, Thomas Bachleitner-Hofmann
Published 2021-02-01

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

by Hossein Taghizadeh, Sabine Zöchbauer‐Müller, Robert M. Mader, Leonhard Müllauer, Thomas Klikovits, Thomas Bachleitner‐Hofmann, Mir A. Hoda, Gerald W. Prager
Published 2020-07-01

Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer.

by Dominic Schauer, Patrick Starlinger, Christian Reiter, Nikolaus Jahn, Philipp Zajc, Elisabeth Buchberger, Thomas Bachleitner-Hofmann, Michael Bergmann, Anton Stift, Thomas Gruenberger, Christine Brostjan
Published 2012-01-01

Immunological differences between colorectal cancer and normal mucosa uncover a prognostically relevant immune cell profile

by Katharina Strasser, Hanna Birnleitner, Andrea Beer, Dietmar Pils, Marlene C. Gerner, Klaus G. Schmetterer, Thomas Bachleitner-Hofmann, Anton Stift, Michael Bergmann, Rudolf Oehler
Published 2019-02-01

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin...

by Marilena Petrera, Laura Paleari, Matteo Clavarezza, Matteo Puntoni, Silvia Caviglia, Irene Maria Briata, Massimo Oppezzi, Eva Mihajlovic Mislej, Borut Stabuc, Michael Gnant, Thomas Bachleitner-Hofmann, Wilfried Roth, Dominique Scherer, Walter-E. Haefeli, Cornelia M. Ulrich, Andrea DeCensi
Published 2018-12-01